SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is drawing significant attention for its strategic expansion into Texas, acquiring extensive land and power infrastructure to support future AI and high-performance computing development. While analysts highlight the company's potential as a dual-play in Bitcoin mining and AI, the community actively anticipates the impact of expected AI contracts and expresses mixed sentiment regarding management's progress in securing these crucial deals.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is trending amidst reports of tight physical silver supply, including the US Mint's halt of sales, which is fueling a significant short squeeze. The community is actively discussing the divergence between paper and physical prices, celebrating substantial gains, and anticipating triple-digit price targets. This rally is further amplified by silver's role as a critical industrial metal and inflation hedge in a climate of geopolitical uncertainty, with recent CME margin adjustments adding pressure to short positions.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull (BULL) is a major talking point as its inclusion in Russell indices and the rollout of its AI-powered Vega decision partner fuel community hopes for increased platform engagement and growth. Despite bullish sentiment citing strong fundamentals, international expansion, and a "Strong Buy" rating, the stock faces skepticism from traders lamenting persistent selling pressure and a perceived disconnect from broader market and crypto upswings, creating a deeply divided outlook.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is a top trending stock following reports it may revise its Warner Bros. Discovery acquisition bid to an all-cash offer, a development viewed by many as a bullish signal of financial strength and deal certainty, yet others see it as a reactive move amid competitive and legal pressures. With its upcoming earnings report, the community is actively debating a potential pre-earnings rally fueled by anticipated strong fundamentals against lingering concerns over market manipulation and the broader implications of its M&A strategy for future growth.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is trending due to significant anticipation surrounding its presentations at the J.P. Morgan Healthcare Conference and a potential PMDA approval in Japan, alongside recent breakthrough data for its alpha radiation therapy in pancreatic cancer. The community is buzzing with excitement over the company's life-saving technology and growing institutional interest, viewing DRTS as an undervalued leader in oncology poised for revaluation.

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management (GWIM), Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The GWIM segment focuses on solutions to meet clients’ needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 and is headquartered in Charlotte, NC.

Bank Of America Corp.

Bank of America Corp

Bank of America is trending following its earnings report that surpassed expectations, driven by strong net interest income and solid performance across key segments. Community sentiment is buoyed by the company's positive outlook for future growth, its strategic AI investments, and recent analyst upgrades naming it a top large-cap bank pick.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup is trending after its Q4 earnings presented a mixed performance, with several key revenue segments beating estimates despite reported misses on headline EPS and total revenue. This has fueled diverse community perspectives, with some expressing bullishness on the underlying strength while others debate the initial market reaction. Broader discussions include the company's extensive transformation strategy involving job cuts and recent regulatory advancements.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending after reporting strong preliminary Q4 revenue figures and optimistic 2026 guidance for its MS drug Briumvi at a major healthcare conference. The community is actively discussing Briumvi's accelerated market share growth and its potential to achieve blockbuster status, especially as a key competitor faced a significant regulatory setback. This robust operational performance, combined with Briumvi's favorable profile, is fueling speculation about potential analyst upgrades and increased M&A interest from larger pharmaceutical companies.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is seeing intense discussion ahead of its "Eos in Focus" investor update, following the recent launch of its Indensity battery storage architecture. The community is keenly anticipating potential announcements regarding major deals with hyperscalers or data centers, leveraging its non-flammable, US-made zinc battery technology to address growing energy demands. While some traders eye profit-taking, many view market pullbacks as opportunities to accumulate shares, betting on the company's long-term growth and potential for a short squeeze.

ProShares Trust - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver (AGQ) is generating intense conversation due to expectations of China's impending silver export restrictions and escalating industrial demand from sectors like EVs and AI. While a strong bullish sentiment anticipates further price surges and a 'squeeze', a vocal segment of the community warns of an overextended 'tulip craze' and potential for a sharp 'rug pull' amid signs of speculative excess and market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NMRA Proof of concept validates the asset, perceived scarcity drives the valuation as the price isn&#39;t set by the seller—it&#39;s set by the competitive pressure of the last bidder.

Glenn Thomas

StockTwits Web

Neumora Therapeutics Inc.

 Proof of concept validates the asset, perceived scarcity drives the valuation as the price isn't set by the seller—it's set by the competitive pressure of the last bidder.

Oscar Health Inc - Ordinary Shares - Class A

BioAge Labs Inc.

AlphaDesk Wealth

@AlphaDeskWealth Chart needs another fuse/catalyst it appears.  Downward pressure on relatively low volume.

 Chart needs another fuse/catalyst it appears.  Downward pressure on relatively low volume.

AMGEN Inc.

Lilly(Eli) & Co

Novo Nordisk A/S

Pfizer Inc

Hims & Hers Health Inc

Ventyx Biosciences Inc

Metsera Inc

Craig Marc Goodstadt

@InvestorCG capital is temporarily prioritizing $BIOA due to their recent clinical &quot;proof of concept&quot; data. 
 
Historically, when one leader in a &quot;niche&quot; sector reports massive data, investors often rotate into that lead asset before returning to the next peer in line. 
 
JPM conference reports will only be actioned in the next week.

 due to their recent clinical "proof of concept" data. 
 
Historically, when one leader in a "niche" sector reports massive data, investors often rotate into that lead asset before returning to the next peer in line. 
 
JPM conference reports will only be actioned in the next week.